AAMP Spring May 17-19th, 2024 CME Quiz Step 1 of 4 25% Name* First Last Email Address*Phone Number* FRIDAY 8:15 – 8:45 Dr. Anderson Neurodiversity: It's not what we were all taught (and that's a good thing!)Neurodiversity, according to this presentation, is:* a. Limited to ADD b. Includes ADD and PANS only c. A&B d. None are true The concept of “spectrum” as described in this presentation:* a. Is NOT like a ‘thermometer’ or ‘small-medium-large’ scale. b. May have very positive aspects, neutral features, and pathogenic features. c. All are true d. None are true 8:45 – 9:15 Dr. Anderson Endogenous Neurotoxicity: An Orthomolecular Approach Part – 1 Sulfites and SalicylatesSulfite Oxidase requires which cofactor?* a. Molybdenum b. Ascorbate c. Thiamine d. All of these One therapeutic idea is dietary restriction of salicylates:* a. True b. False 9:15 – 10:15 Dr. Mary Rondeau ADHD: Beyond Dopamine This presentation described _______ etiologies for ADHD:* a. One b. Two c. Multiple One etiology includes:* a. Methylation a. Mitochondrial b. Inflammatory c. All of these 11:00 – 12:00 Dr. Steve Rondeau Embracing neuro-individuality through EEGThis presentation described ______ as a brain type assessment:* a. Written surveys b. Blood Testing C. QEEG d. All of these Brainwave descriptions were included in this presentation:* a. True b. False 1:45 – 2:45 Dr’s Mary and Steve Rondeau Neurodiversity in practice: Case DiscussionsOne case included a 15 year old male, with moderate to severe ADHD, Inattentive Type* a. True b. False Some assessments included in the cases were:* QEEG b. Food sensitivity c. OAT d. All of these 2:45 – 3:15 Dr. Anderson Endogenous Neurotoxicity: An Orthomolecular Approach Part – 2 Aldehydes, Histamine, and PyrrolesAldehyde toxicity enzymes:* a. Do not exist b. Include only ONE step c. Require two or more steps d. None of these Histamine has ____ primary eliminatory pathways:* 1 2 3 4 4:30 – 5:00 Dr. Anderson Endogenous Neurotoxicity: An Orthomolecular Approach Part – 3 Oxalates and Nitrogen-AmmoniaOxalates can cause symptoms in:* a. Urinary tract b. Muscle c. Brain d. All of these Hyperbaric Oxygen may help in nitrogen toxicity:* a. True b. False 5:00 – 5:30 Dr. Anderson Concepts in well-balanced Depuration and DetoxificationIn this presentation the idea was promoted:* a. Nobody is toxic with just one thing b. Starting depuration & detox for one toxicant will start other toxicants to eliminate c. Support can be designed to cover multiple toxicant types in one treatment planv d. All of these Concepts discussed included:* a. Detoxification vs Depuration b. Use of GI-Bile binders c. Hydration d. All of these SATURDAY 8:15 – 9:35 Dr. Anderson: Specific Therapies for Brain Mitochondria – Orthomolecular & Beyond The brain has ______ mitochondria per cell:* Few Many This is unknown Supports mentioned included:* a. NAD b. Methylene Blue c. B-Vitamins d. All of these The point was made in this presentation that:* a. Mitochondrial therapies are useful in neurodiverse people b. Only support with NAD can be helpful in neurodiversity c. All of these 10:20 – 11:50 Dr. Gannage Environmental factors including the impact of pesticides and metals on neurodevelopmentnessThis presentation postulated that:* Pesticides are innocuous Pesticides are of unknown scientific importance Pesticides aggravate brain function Pesticides aggravate brain function This presentation postulated that:* Metals are innocuous Metals are of unknown scientific importance Metals ls aggravate brain function None of these 1:45 – 3:15 Dr. Gannage Diet interventions and cellular nutrition for ASDThis presentation promoted a diet:* a. High in sugars b. Low in protein c. Both of these d. None of these In this presentation, micronutrient therapies were considered:* a. Helpful b. Useless c. Of unknown clinical value 4:30 – 5:30 Dr. Crista PANS-PANDAS Part 1: Infectious and Environmental TriggersThis presentation made it clear that Group-A beta hemolytic Strep. (GABS) were:* a. The only infectious etiology b. One of many infectious etiologies c. This presentation did not include GABS This presentation included chemical and metal toxicants as possible etiologies:* a. True b. False SUNDAY 8:30 – 9:30 Dr. Crista PANS-PANDAS Part 2: Conventional Treatment ApproachesAnti-inflammatory drugs:* a. Were included b. Were not included c. Only included NSAIDS d. None of these Antibiotic management and considerations:* a. Were included b. Were not included c. Only included Beta-lactam drugs d. None of these 9:30 – 10:30 Dr. Crista PANS-PANDAS Part 3: An Integrative Approach to TreatmentThe “core four” included: Anti-inflammatories, Antimicrobials, Immune modulation, Infection/toxicant prevention.* a. True b. False In this presentation, herbal (botanical) medications:* a. Were not discussed b. Were discussed in detail c. Were limited to three herbs d. None of these 11:15 – 12:15 Dr. Kruppstadt Assessment and Diagnosis: From the current accepted definition of autism and the standard of medical care for evaluation and treatment, to a systems biology approach using case examples.The goals and objectives of this presentation were:* a. Have an awareness of the common biological systems present in autistic patients that may be impacted and lead to imbalance and dysfuction b. Confidently design an approach for the initial evaluation and treatment of a patient with autism c. Both A&B d. Neither A nor B This presentation asserted that:* a. Autism rates have increased greatly since 2000 b. Boys are diagnosed more than girls c. Both A&B d. Neither A nor B 1:15 – 2:15 Dr. Kruppstadt Utilizing nutrigenomics in a “boots on the ground” systems biology approach (not overwhelming, like so many introductions to genetics) to intervene early on.The discussion of the clinical use of genomics in this presentation was:* a. Focused and clinically relevant b. Very broad c. Not included This presentation included possible cytokines to assess:* True False 2:15 – 3:15 Dr. Kruppstadt Testing echelons and alternative therapies that are needle movers:List what specific tests to initially order from commercial laboratories to evaluate your neurodiverse patients was included in this presentation:* True False This presentation included concepts:* a. Explain where to begin your testing for the neurodiverse patient b. Discuss why genetic testing and innate immune system testing must be done very early in the evaluation of the neurodiverse patient c. Both A&B d. None of these 3:30 – 4:00 Dr. Anderson What do we do Monday Morning?This presentation:* a. Focused heavily on specific sub-types of lab tests b. Focused on the use of SPECT scanning c. Both of these d. None of these This presentation promoted the idea that you can clinically help the neurodiverse patient:* True False